Shortage of Novo’s Wegovy and Ozempic is resolved, FDA website shows

A shortage of Danish drugmaker Novo Nordisk’s popular weight-loss and diabetes drugs, Wegovy and Ozempic, has been resolved, the U.S. Food and Drug Administration’s website showed on Friday.